2022 Solid Organ Transplantation Technologies Report: eHealth Services and Transplant Management Solutions Present Opportunities
28 mars 2023 10h48 HE
|
Research and Markets
Dublin, March 28, 2023 (GLOBE NEWSWIRE) -- The "Solid Organ Transplantation Technologies and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The study covers...
North America Kidney Transplant Market Research Report 2023: Calcineurin Inhibitors Revenue will Grow Due to Advancement and Technology in the Healthcare Industry
27 mars 2023 08h58 HE
|
Research and Markets
Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "North America Kidney Transplant Market, Size, Forecast 2023-2027, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company...
Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 30, 2023
23 mars 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it plans to release financial results for the fourth quarter and full...
Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023
23 mars 2023 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 23, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will present two posters at the upcoming International...
Eledon Pharmaceuticals to Present at SVB Securities Global Biopharma Conference
08 févr. 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, Chief Executive Officer, will present at the...
Eledon Pharmaceuticals Provides Business and Pipeline Updates
09 janv. 2023 08h31 HE
|
Eledon Pharmaceuticals, Inc.
Company plans to prioritize and focus resources on the advancement of tegoprubart in kidney transplantation Continued enrollment in open-label Phase 1b kidney transplant trial with initial data...
Insights on the Flow Cytometry Global Market to 2027 - Increasing Use of Flow Cytometry in Cellular Therapy Development Presents Opportunities
05 janv. 2023 08h28 HE
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Flow Cytometry: Products, Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide a...
C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
21 déc. 2022 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path) announced on December 20, 2022, that its Transplant Therapeutic Consortium (TTC) received a qualification opinion...
Immucor and Pirche announce multi-year partnership
04 oct. 2022 08h04 HE
|
Immucor, Inc.
NORCROSS, Ga. and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global leader in AI-powered molecular...
Global Organ Transplant Market Report 2022: Rising Need for Innovative Tissue Transplantation Products and Organ Transplantation to Treat Organ Failure Propelling Sector
06 sept. 2022 05h23 HE
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Organ Transplant Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering.A major element driving...